Jan Stern Reed - 15 Jul 2026 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Reporting relationship: Director
Issuer ticker: ANGO
Reported as of: 15 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Jul 2026, 20:06:15 UTC
Prior SEC filing: 04 Jun 2026
Next SEC filing: 28 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Lawrence T. Weiss, Attorney in Fact

Key filing fact

Jan Stern Reed filed Form 4 for ANGIODYNAMICS INC (ANGO) on 22 Jul 2026.

Key facts

This page summarizes Jan Stern Reed's Form 4 filing for ANGIODYNAMICS INC (ANGO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Jul 2026, 20:06.

Change

Previous filing in this sequence was filed on 04 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001124181 Primary reporting owner

REED JAN STERN

Relationship: Director
Address: 14 PLAZA DRIVE, LATHAM
Signature: /s/ Lawrence T. Weiss, Attorney in Fact
Signature date: 22 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANGO transaction

Common Stock

Award

Transaction value
Shares: +11,887
Change %: +11%
Price: $0.000000^*
Shares after: 116,921
Date: 15 Jul 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant.